At the Medicap Pharmacy® stores, we are dedicated to providing products and services to care for your family’s wellness. One of those services is health news you can trust. Use the filters to focus on the information that is important to you, then bookmark this page to make it a regular stop anytime you’re online.
Trends in Treating Diabetes
Diabetes is a big problem in the US — and thus, it is a big focus of doctors, researchers and pharmaceutical companies alike. New medications and developments alter how diabetes is treated.
FDA Investigating Risk of Pancreatitis in Type 2 Diabetes Meds
The US Food and Drug Administration (FDA) is evaluating unpublished new findings by a group of academic researchers that suggest an increased risk of pancreatitis, or inflammation of the pancreas, and pre-cancerous cellular changes called pancreatic duct metaplasia in patients with type 2 diabetes treated with a class of drugs called incretin mimetics.
Teenage Waistband: Diabetes Rx May Fight Fat
Teen obesity is a growing health problem. The percentage of US adolescents who are overweight has more than tripled over the last 20 years. One diabetes Rx may help teens lose weight.
Seeking Approval of New Diabetes Med
For many diabetes patients, diet and exercise alone isn't enough to control blood sugar levels. These patients need medications. And they may need more options. A new diabetes medication is at the start of the approval process.
Diabetes Rx Go Head-to-Head
With all the available treatment options for type 2 diabetes, it can be hard to tell which one is right for which patient. A recent study addressed this difficulty with a comparison of two medications.
Diabetes Drug Could Slow Speedy Addicts
In most cases, a drug is first created to treat one disease. Later down the road, however, researchers may find that the drug can be used for other purposes - which is the case now with a certain diabetes drug.
Byetta Approved for Use With Basal Insulin
Amylin Pharmaceuticals, Inc. and Eli Lilly and Company BYETTA ( exenatide twice-daily) as an adjunctive therapy to basal insulin, with or without metformin and/or Actos ( pioglitazone ), for the treatment of type 2 diabetes in adults who have not achieved adequate glycemic control with these agents.
Turning Around Type 2
Type 2 diabetes may be the most common form, affecting millions of Americans. That doesn't mean it has to be a chronic condition. A healthy lifestyle can help you turn around the disease and live free of medication.
Bydureon Approved for Type Two Diabetes
Some diabetes drugs have to be taken multiple times a day. For many patients, it can be hard to stay on such a strict schedule. Now, patients have the option of a once-weekly drug for type 2 diabetes.
The Byetta Bonus
In many cases, drugs can have harmful side effects. They also can have unintended uses and benefits. Sometimes a drug designed to treat one disease has the power to treat an entirely different disorder.